SQSTM1 and hepatocellular carcinoma: Taken together, these results further showed that SQSTM1/p62 has a great impact on the migration and invasion of HCC, and pathological or pharmacological regulation of SQSTM1/p62 could be a key strategy in the treatment of HCC in the future.